The addition of calcium phosphate fillers or antimicrobials to bone cements seems to produce inferior materials. In this study, a two-solution bone cement composite was designed for high viscosity and high pseudoplasticity to improve injection and mitigate the risk of extravasation. By pre-mixing these cements, the fillers are incorporated into the matrix and should not detrimentally affect the performance properties. To expand the functionality of this cement system, the addition of bioactive and antimicrobial phases were explored. Brushite and chlorhexidine were used as calcium phosphate filler and the antimicrobial phase, respectively. By controlling the free radical quenching mechanism provided by the chlorhexidine molecule, it was possible to achieve high polymer conversion rates. This phenomenon led to cement strength retention while successfully preventing microbial proliferation in an environment exposed to the cement surface. Based on these results, two-solution cement composite prepared with high concentrations of brushite and chlorhexidine diacetate salt hydrate may provide an attractive bioactive and antimicrobial cement for load-bearing applications.
RodriguezLCChariJAghyarianS. Preparation and characterization of injectable brushite filled-poly(methyl methacrylate) bone cement. Materials2014; 7: 6779–6795.
2.
HendricksJGEvan HornJRvan der MeiHC. Backgrounds of antibiotic-loaded bone cement and prosthesis-related infection. Biomaterials2004; 25: 545–556.
3.
SimchiATamjidEPishbinF. Recent progress in inorganic and composite coatings with bactericidal capability for orthopedic applications. Nanomedicine2011; 7: 22–39.
4.
RosenthalALRovellJMGirardAE. Polyacrylic bone cement containing erythromycin and colistin. I. In vitro bacteriological activity and diffusion properties of erythromycin colistin and erythromycin/colistin combination. Int Med Res1976; 4(5): 296–304.
5.
JosefssonGLindbergLWiklanderB. Systemic antibiotics and gentamicin-containing bone cement in the prophylaxis of postoperative infections in total hip arthroplasty. Clin Othop1981; 159: 194–200.
6.
KlekampJDawsonJMHaasDW. The use of vancomycin and tobramycin in acrylic bone cement: biomechanical effects and elution kinetics for use in joint arthroplasty. J Arthroplasty1999; 14(3): 339–346.
7.
LautenschlagerEPJacobsJJMarshallGW. Mechanical properties of bone cements containing large doses of antibiotic powders. J Biomed Mater Res1976; 10(6): 929–938.
8.
LacyMKNicolauDPNightingaleCH. The pharmacodynamics of aminoglycosides. Clin Infect Dis1998; 27: 23–27.
9.
TrippelSB. Antibiotic-impregnated cement in total joint arthroplasty. J Bone Joint Surg Am1986; 68: 1297–1302.
10.
WroblewskiBMEsserMSrigleyDW. Release of gentamicin from bone cement. An ex-vivo study. Acta Orthop Scand1986; 57: 413–414.
11.
PowlesJWSpencerRFLoveringAM. Gentamicin release from old cement during revision hip arthroplasty. J Bone Joint Surg Br1988; 80: 607–610.
12.
Van de BeltHNeutDVan HornJR. …or not to treat? (Letter to Editor). Nat Med1999; 5: 358–359.
13.
MerkhanIKHasenwinkelJMGilbertJL. Gentamicin release from two-solution and powder-liquid poly(methyl methacrylate)-based bone cements by using novel pH method. J Biomed Mater Res A2004; 69(3): 577–583.
14.
KoganPHeJGlickmanG. The effects of various additives on setting properties of MTA. J Endod2006; 32(6): 569–572.
15.
HoltDWattsJBeesonT. The anti-microbial effect against enterococcus faecalis and the compressive strength of two types of mineral trioxide aggregate mixed with sterile water or 2% chlorhexidine liquid. J Endod2007; 33(7): 844–847.
16.
StoweTSedgleyCStoweB. The effects of chlorhexidine gluconate (0.12%) on the antimicrobial properties of tooth-colored proroot mineral trioxide aggregate. J Endod2004; 30(6): 429–431.
17.
HasenwinkelJMLautenschlagerEPWixsonRL. A novel high-viscosity, two-solution acrylic bone cement: effect of chemical composition on properties. J Biomed Mater Res1999; 47: 36–45.
18.
GilbertJLHasenwinkelJMRodriguesDC. Pseudoplasticity and setting properties of two-solution bone cement containing poly(methyl methacrylate) microspheres and nanospheres for kyphoplasty and vertebroplasty. J Biomed Mater Res B Appl Biomater2009; 91(1): 248–256.
19.
ZhongMLChenXQFanHF. Incorporation of salmon calcitonin-loaded poly(lactide-co-glycolide) (PLGA) microspheres into calcium phosphate bone cement and the biocompatibility evaluation in vitro. J Bioact Compat Polym2012; 27: 133–147.
20.
ASTM F451-08. Standard specifications for acrylic bone cement. West Conshohocken, PA: ASTM International, 2008.
21.
BechertTSteinrückePGuggenbichlerJP. A new method for screening anti-infective biomaterials. Nat Med2000; 6: 1053–1056.
22.
AltVBechertTSteinrückeP. In vitro testing of antimicrobial activity of bone cement. Antimicrob Agents Chemother2004; 48(11): 4084–4088.
23.
SahmDFKissingerJGilmoreMS. In vitro susceptibility studies of vancomycin-resistant enterococcus faecalis. Antimicrob Agents Chemother1989; 33(9): 1588–1591.
24.
SievertDMRicksPEdwardsJR. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infect Contr Hosp Epidemiol2013; 34(1): 1–14.
25.
McDonnellGRussellAD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev1999; 12(1): 147–179.
26.
DaviesGEFrancisJMartinAR. 1:6-di-4′-chlorophenyldiguanidohexane (“hibitane”). Laboratory investigation of a new antibacterial agent of high potency. Brit J Pharmacol1954; 9: 192–196.
27.
BotelhoM. Compressive strength of glass ionomer cements with dental antimicrobial agents. SADJ2004; 59(2): 51–53.
28.
ShahiSRahimiSYavariH. Sealing ability of white and gray mineral trioxide aggregate mixed with distilled water and 0.12% chlorhexidine gluconate when used as root-end filling material. J Endod2007; 33(12): 1429–1432.
29.
ChoiKKuhnJLCiarelliMJ. The elastic moduli of human subchondral, trabecular, and cortical bone tissue and the size-dependency of cortical bone modulus. J Biomech1990; 23(11): 1103–1113.
30.
GuvenmGSUzunO. Principle of good use of antibiotics in hospitals. J Hosp Infect2003; 53: 91–96.
31.
JonesJHenchL. Regeneration of trabecular bone using porous ceramics. Curr Opin Solid State Mater Sci2003; 7(4–5): 301–307.
